Key result
Losartan and enalapril completely inhibited the age-related increase in systolic blood pressure in SHR and reduced left ventricular ANP mRNA, but had no effect on left ventricular ADM gene expression.
Why the study?
Does losartan or enalapril affect cardiac ADM, ANP, and BNP gene expression in normotensive and hypertensive rats?
Does losartan or enalapril affect cardiac ADM, ANP, and BNP gene expression in normotensive and hypertensive rats?
Ventricular ADM synthesis is an insensitive marker of changes in hemodynamic load or cardiac hypertrophy compared to ANP and BNP.
Answers are grounded in this paper and cite their sources.
ADM expression unaffected by BP control unlike ANP in SHR; leaves open its value as a cardiac load marker.
OBJECTIVE: To study the effects of long-term treatment with the type 1 angiotensin (AT1) receptor antagonist losartan and the angiotensin-converting enzyme (ACE) inhibitor enalapril, on cardiac adrenomedullin (ADM), atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) gene expression. METHODS: Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were given losartan (15 mg/kg per day) or enalapril (4 mg/kg per day) orally for 10 weeks. The effects of drugs on systolic blood pressure, cardiac hypertrophy, ANP, BNP and ADM mRNA and immunoreactive-ANP (IR)-ANP, IR-BNP and IR-ADM levels in the left ventricle and atria were compared. RESULTS: Losartan and enalapril treatments completely inhibited the increase of systolic blood pressure occurring with ageing in SHR. The ratio of heart to body weight was reduced in both losartan- and enalapril-treated SHR and WKY rats. Treatment with losartan or enalapril reduced left ventricular ANP mRNA and IR-ANP in both strains, and ventricular BNP mRNA levels in SHR rats. Inhibition of ACE, AT1 receptor antagonism, changes in blood pressure or cardiac mass had no effect on left ventricular ADM gene expression in SHR and WKY rats. In addition, atrial IR-ANP and IR-ADM levels increased in SHR whereas IR-BNP levels decreased in WKY and SHR rats in response to drug treatments. CONCLUSIONS: Our results show that ventricular ADM synthesis is an insensitive marker of changes in haemodynamic load or cardiac hypertrophy. Furthermore, the expression of ADM, ANP and BNP genes is differently regulated both in the left ventricle and atria in response to AT1 receptor antagonism and ACE inhibition.
No takes yet. Share an insight, caveat, or question.
Magga et al. (1999) studied Hypertension. Losartan or enalapril was evaluated on Effects on systolic blood pressure, cardiac hypertrophy, ANP, BNP and ADM mRNA and immunoreactive levels. Losartan and enalapril completely inhibited the age-related increase in systolic blood pressure in SHR and reduced left ventricular ANP mRNA, but had no effect on left ventricular ADM gene expression.
Synapse has enriched 10 related papers. Consider them for comparative context: